Viral Clearance MasterClass

When developing a process for the manufacture of therapeutical recombinant proteins expressed in mammalian cell lines, gene therapy and cell therapy products, the biotherapeutics should not generate a risk of viral contamination of the patients. This online training will give an overview of the sources and impacts of viral contaminations of biotherapeutics, how to prevent those risks and how to evaluate the capability of the process.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #viralclearance


Out Now!


Add Comment

Click here to post a comment